rapid
detect
influenza
parainfluenza
virus
rsv
recent
hmpv
convent
perform
use
direct
fluoresc
antigen
stain
enzym
immunoassay
immunofluoresc
assay
direct
enterovirus
also
appli
picornaviru
detect
respiratori
specimen
mani
case
approach
remain
rapid
mean
detect
etiolog
agent
outbreak
despit
lower
sensit
molecular
method
addit
rapid
antigen
test
avail
influenza
rsv
assay
low
sensit
compar
cultur
molecular
method
sensit
antigen
test
influenza
virus
may
low
compar
cultur
significantli
lower
sensit
direct
fluorescentantibodi
assay
analyt
sensit
rapid
antigen
method
detect
influenza
approxim
four
tissu
cultur
infect
dose
electron
microscop
detect
virus
replac
mani
laboratori
method
approach
disadvantag
term
high
cost
equip
signific
expertis
requir
prepar
specimen
interpret
result
lower
sensit
molecular
method
howev
examin
negativestain
specimen
prepar
offer
rapid
mean
scan
wide
rang
virus
may
detect
specif
molecular
assay
stain
procedur
addit
electron
microscopi
may
use
identif
virus
grown
cell
cultur
particularli
previous
unrecogn
virus
convent
cultur
isol
respiratori
virus
usual
involv
inocul
specimen
onto
least
three
cell
line
includ
primari
monkey
kidney
cell
human
diploid
fibroblast
cell
human
heteroploid
cell
line
inocul
cultur
usual
incub
least
day
cultur
respiratori
specimen
usual
incub
rotat
drum
encourag
faster
growth
respiratori
virus
earlier
detect
cytopath
effect
cultur
perform
shell
vial
centrifug
much
rapid
convent
tube
monolay
usual
give
result
within
hour
similarli
cocultur
mixtur
cell
type
use
rapid
detect
respiratori
virus
approach
disadvantag
fixat
stain
limit
rang
virus
detect
singl
cultur
reagent
becom
avail
newli
recogn
viral
pathogen
number
shell
vial
inocul
increas
addit
cost
decis
appli
multiplex
panel
test
specimen
must
trigger
recognit
outbreak
given
rel
high
perspecimen
cost
multiplex
molecular
assay
often
impract
appli
assay
specimen
potenti
outbreak
therefor
becom
standard
practic
test
sampl
specimen
larg
outbreak
basi
limit
test
small
number
sampl
outbreak
deriv
studi
noroviru
outbreak
detect
howev
earli
specimen
collect
import
sensit
approach
exploit
excret
viru
detect
rate
declin
first
day
ill
convent
virolog
method
use
detect
identif
viral
respiratori
pathogen
remain
use
circumst
convent
method
prefer
molecular
method
rang
biolog
technic
reason
exampl
cultur
virus
permit
full
identif
character
viru
isol
includ
phenotyp
confirm
antivir
suscept
moreov
cultur
often
detect
novel
strain
emerg
virus
convers
molecular
method
often
sensit
limit
intend
target
viru
requir
knowledg
genom
sequenc
provid
complet
templat
molecular
assay
develop
rapidli
thu
failur
detect
target
molecular
assay
rule
absenc
viru
includ
assay
counter
practic
abil
rapidli
design
detect
new
virus
use
degener
primer
greater
sensit
offer
molecular
method
also
come
cost
higher
qualiti
control
standard
assur
program
prevent
detect
fals
posit
due
contamin
laboratori
use
nucleic
acid
amplif
technolog
must
take
precaut
prevent
fals
posit
result
might
aris
contamin
specimen
amplif
product
previous
analyz
specimen
avoid
contamin
workflow
must
strictli
unidirect
movement
specimen
materi
revers
direct
ideal
procedur
carri
four
physic
separ
room
dedic
task
reagent
prepar
specimen
prepar
reaction
setup
postamplif
analysi
importantli
postamplif
room
exhaust
air
neg
pressur
rel
laboratori
reagent
prepar
room
suppli
air
posit
pressur
rel
laboratori
laboratori
dedic
equip
suppli
lab
coat
use
sticki
mat
dedic
personnel
strict
handwash
polici
help
unwant
spread
amplicon
outsid
postamplif
room
monitor
environment
swab
comparison
convent
virolog
less
prone
contamin
issu
molecular
method
inhous
homebrew
assay
also
requir
user
valid
analyt
limit
detect
importantli
clinic
sensit
specif
gener
manufactur
assay
perform
specif
state
manufactur
must
verifi
modif
origin
assay
must
alway
follow
reestablish
perform
specif
inhous
assay
establish
perform
specif
assay
must
done
appropri
sampl
type
supplier
lot
differ
analytespecif
reagent
typic
lack
perform
specif
therefor
effect
assay
perform
must
reestablish
user
chang
reagent
supplier
even
reagent
lot
supplier
typic
supplier
manufactur
assay
provid
qualiti
control
assur
anoth
disadvantag
molecular
method
convent
virolog
techniqu
molecular
approach
often
requir
batch
process
specimen
batch
specimen
often
queu
process
format
necessari
extract
process
subsequ
amplif
detect
step
convers
rapid
antigen
detect
assay
direct
fluoresc
antibodi
method
complet
less
hour
test
start
specimen
arriv
laboratori
process
step
done
individu
therefor
driven
requir
batch
process
common
highthroughput
molecular
method
despit
limit
molecular
assay
discuss
classic
method
cultur
becom
secondari
tier
triag
diagnost
option
investig
institut
outbreak
larg
driven
increas
sensit
specif
molecular
diagnost
assay
afford
exampl
influenza
molecular
assay
shown
sensit
littl
two
viru
particl
per
microlit
howev
molecular
assay
found
even
sensit
practic
sinc
amplif
technolog
detect
nonviabl
viru
make
molecular
diagnost
assay
severalfold
sensit
cultur
outbreak
investig
specimen
collect
handl
transport
condit
less
ideal
comparison
cultur
molecular
assay
also
provid
much
faster
time
result
vital
effect
intervent
outbreak
investig
consequ
multitarget
molecular
assay
becom
cost
effect
increas
cost
test
offset
reduct
patient
care
cost
possibl
earlier
diagnost
result
econom
advantag
even
pronounc
outbreak
investig
time
result
utmost
import
prevent
spread
diseas
within
institut
howev
specif
molecular
assay
mean
laboratori
must
circumv
potenti
limit
either
multitarget
approach
set
sever
individu
molecular
assay
target
differ
viru
class
virus
multiplex
pcr
assay
respiratori
virus
retain
good
sensit
proper
valid
howev
singletarget
pcr
easiest
assay
valid
best
sensit
specif
lack
competit
inhibit
effect
compromis
buffer
thermal
cycl
condit
often
necessari
optim
multiplex
pcr
moreov
compar
singletarget
assay
may
refer
uniplex
monoplex
singleplex
assay
multiplex
assay
requir
qualiti
control
complex
perform
evalu
data
analysi
algorithm
complex
report
result
essenti
increas
number
reaction
multiplex
assay
entail
stringent
requir
sampl
puriti
sampl
input
reagent
instrument
avoid
nonspecif
amplif
obscur
background
signal
multitarget
approach
often
accomplish
multiplex
amplif
target
nucleic
acid
sever
nucleic
acid
amplif
technolog
establish
review
elsewher
exampl
amplif
perform
use
multiplex
version
pcr
product
amplicon
reaction
need
demultiplex
proper
detect
identif
viru
demultiplex
done
varieti
technolog
includ
limit
probebas
fluoresc
differenti
capillari
gel
electrophoresi
microarray
technolog
luminex
bead
flow
cytometr
analysi
mass
spectrophotometri
follow
section
highlight
approach
specif
exampl
current
avail
use
investig
respiratori
viral
outbreak
extens
review
cover
broader
scope
molecular
assay
use
outbreakrel
viral
detect
character
publish
use
molecular
assay
gener
signific
inform
epidemiolog
respiratori
viral
outbreak
readili
obtain
use
convent
method
coinfect
involv
two
virus
previous
detect
often
detect
frequent
use
molecular
method
tabl
mani
involv
virus
formerli
undetect
simpli
sought
use
convent
method
addit
mani
outbreak
shown
involv
multipl
virus
circul
within
institut
initi
studi
institut
outbreak
use
multiplex
approach
multipl
virus
detect
eight
outbreak
pcr
assay
develop
outbreak
investig
typic
fall
two
categori
multitarget
pcr
use
consensu
univers
primer
sever
singleplex
pcr
use
triag
manner
exampl
detect
novel
strain
influenza
done
univers
primer
typespecif
singleplex
pcr
reflex
manner
typic
combin
univers
primer
specif
primer
use
outbreak
investig
good
exampl
influenza
screen
approach
wherebi
laboratori
start
broadspectrum
singleplex
pcr
base
highli
conserv
matrix
gene
followup
type
posit
identifi
influenza
specimen
use
typespecif
pcr
hemagglutinin
gene
either
case
combin
primer
array
singleplex
pcr
design
provid
process
elimin
hone
viral
pathogen
interest
therebi
identifi
caus
outbreak
agent
combin
pcr
chemistri
fluoresc
probe
detect
amplifi
product
reaction
tube
arguabl
fastest
robust
inhous
pcr
techniqu
provid
realtim
result
appropri
instrument
contamin
contain
closedtub
amplif
requir
postpcr
manipul
reduc
implement
cost
due
robust
natur
sever
realtim
pcr
probe
technolog
exist
nucleas
probe
life
technolog
corpor
carlsbad
ca
usa
molecular
beacon
fluoresc
reson
energi
transfer
fret
hybrid
probe
howev
multiplex
challeng
need
avoid
fluoresc
crosstalk
analysi
fluoresc
signal
aid
spectral
calibr
associ
target
probe
proper
wavelength
theoret
limit
five
target
diagnost
practic
howev
realtim
multiplex
difficult
optim
often
seen
fewer
five
target
commonli
realtim
pcr
use
singletarget
assay
avoid
competit
inhibit
wherebi
one
target
preferenti
amplifi
one
multiplex
target
sever
exampl
commerci
avail
assay
categori
perhap
best
studi
valid
exampl
proflu
assay
genprob
inc
san
diego
ca
usa
assay
multiplex
realtim
revers
transcript
rt
pcr
detect
influenza
viru
influenza
b
viru
rsv
although
assay
develop
inhous
offer
best
combin
term
perspecimen
cost
flexibl
import
note
assay
must
also
pass
rigor
valid
studi
implement
fals
neg
due
low
sensit
fals
posit
due
low
specif
must
elimin
implement
outbreak
investig
consequ
startup
cost
inhous
method
greater
commerci
avail
molecular
method
may
mean
higher
initi
capit
cost
necessari
equip
wherea
commerci
avail
assay
often
establish
without
equip
purchas
technolog
seegen
inc
seoul
korea
good
exampl
multiplextarget
molecular
assay
use
electrophoresi
mean
demultiplex
multipl
target
respiratori
viru
rv
assay
use
multiplex
pcr
novel
primer
design
call
dual
prime
oligonucleotid
dpo
system
compar
convent
primer
dpo
system
advantag
wider
rang
suitabl
anneal
temperatur
time
maintain
high
specif
accomplish
use
two
prime
region
join
polydeoxyinosin
linker
instead
usual
singl
prime
region
assay
first
use
dpo
system
design
amplifi
detect
adenoviru
influenza
viru
type
b
rsv
subgroup
b
parainfluenza
viru
type
coronaviru
type
hmpv
human
rhinoviru
use
assay
alreadi
demonstr
outbreak
investig
assay
avail
addit
rhinoviru
c
bocaviru
type
parainfluenza
viru
enteroviru
target
exampl
microarray
technolog
respiratori
viral
panel
rvp
plu
autogenom
inc
carlsbad
ca
usa
design
detect
common
respiratori
virus
influenza
swine
influenza
b
parainfluenza
viru
type
rhinoviru
type
b
enteroviru
type
b
c
coronaviru
strain
hmpv
type
b
rsv
subgroup
b
adenoviru
type
b
c
e
assay
work
foundat
multiplex
pcr
coupl
targetspecif
primer
extens
tspe
process
use
tag
primer
fluoresc
nucleotid
tag
extens
product
hybrid
antitag
immobil
microarray
autogenom
inc
novel
filmbas
microarray
consist
multipl
layer
hydrogel
matric
solid
support
comparison
rvp
assay
set
singleplex
realtim
pcr
virus
show
although
assay
sensit
concord
result
outbreak
investig
low
number
sampl
need
sameday
result
microarray
approach
may
best
choic
howev
consid
substanti
reduct
handson
time
microarraybas
assay
viabl
option
higher
volum
sampl
rvp
abbott
molecular
diagnost
abbott
park
il
usa
resplex
panel
qiagen
inc
mississauga
canada
multicodeplx
rvp
eragen
bioscienc
madison
wi
usa
exampl
postpcr
demutiplex
system
use
bead
flow
cytometr
analysi
system
oper
luminex
instrument
detect
platform
use
laser
read
colorcod
microspher
attach
specif
nucleic
acid
sequenc
viral
nucleic
acid
extract
sampl
multiplex
rtpcr
reaction
carri
optim
condit
result
amplicon
virusessubtyp
present
sampl
rtpcr
product
treat
shrimp
alkalin
phosphatas
exonucleas
incorpor
biotindeoxycytidin
triphosph
dctp
tspe
reaction
tspe
effect
help
detect
viral
dna
present
sampl
use
uniqu
sequenc
tag
tspe
reaction
ad
directli
microwel
contain
beadimmobil
antitag
complement
sequenc
tag
primer
bead
spectral
distinguish
use
flow
cytometri
uniqu
color
bead
repres
specif
viru
beadantitagtag
primer
associ
rvp
perhap
bestvalid
commerci
avail
assay
use
bead
flow
cytometr
analysi
origin
cemark
version
rvp
qualit
nucleic
acid
multiplex
test
primer
pair
permit
simultan
detect
identif
multipl
respiratori
viru
nucleic
acid
nasopharyng
swab
nasal
aspir
bronchoaveolar
lavag
suspect
respiratori
tract
infect
follow
viru
type
subtyp
identifi
use
classic
version
cemark
rvp
assay
influenza
subtyp
season
season
influenza
b
rsv
subgroup
b
parainfluenza
viru
type
coronaviru
strain
acut
respiratori
syndrom
coronaviru
sarscov
hmpv
enterorhinoviru
adenoviru
faster
version
rvp
assay
recent
releas
retain
abil
detect
origin
panel
includ
rsv
longer
distinguish
rsv
rsv
b
newer
version
assay
still
detect
influenza
strain
longer
includ
influenza
specif
target
fast
version
also
drop
target
sarscov
instead
detect
human
bocaviru
either
classic
fast
version
rvp
assay
would
use
viral
investig
institut
outbreak
respiratori
natur
current
method
choic
laboratori
version
rvp
assay
detect
influenza
pandem
identifi
influenza
indic
subtyp
effect
make
rvp
assay
sentinel
test
novel
nonseason
influenza
viru
recent
import
full
diagnost
test
outbreak
furthermor
rvp
assay
limit
abil
detect
adenoviru
speci
distinguish
rhinovirus
human
enterovirus
commerci
avail
assay
use
demultiplex
technolog
rvp
resplex
assay
qiagen
multicodeplx
rvp
eragen
resplex
ii
assay
simultan
target
virus
influenza
influenza
influenza
b
rsv
subgroup
b
parainfluenza
viru
type
enterovirus
sarscov
hmpv
rhinoviru
adenoviru
multiplex
respiratori
bacteri
pathogen
resplex
panel
resplex
panel
use
demonstr
coinfect
one
respiratori
pathogen
medic
relev
multicodeplx
rvp
assay
simultan
target
respiratori
virus
subtyp
detect
influenza
subtyp
influenza
b
rsv
subgroup
b
parainfluenza
viru
type
subtyp
coronavirus
hmpv
rhinoviru
adenoviru
type
b
c
e
plexid
abbott
laboratori
exampl
molecular
technolog
use
electrospray
ionizationmass
spectrometri
esim
demultiplex
pcr
essenc
broadli
conserv
primer
site
chosen
permit
identif
target
microb
base
differ
nucleotid
composit
within
amplifi
region
esim
compon
process
help
differenti
mixtur
amplicon
pcr
suffici
accuraci
permit
determin
base
composit
ie
g
c
individu
pcr
product
consequ
technolog
appear
good
potenti
outbreak
investig
right
mixtur
broadspectrum
pcr
good
databas
permit
identif
approach
theoret
specif
postpcr
analysi
amplicon
use
either
size
differenti
electrophoresi
probebas
analysi
realtim
pcr
less
specif
true
dna
sequenc
determin
base
composit
also
actual
sequenc
amplicon
howev
promis
advantag
use
mass
spectrophotometri
demultiplex
stage
pcr
speed
cost
effect
method
abil
deal
mixtur
amplicon
challeng
tradit
dna
sequenc
weak
date
lack
publicdomain
databas
base
composit
attent
given
potenti
mutationassoci
differ
dramat
affect
accuraci
identif
allel
differ
mutat
less
devast
identif
dna
sequenc
base
composit
databas
requir
analysi
yet
develop
fulli
unlik
dna
sequenc
data
current
avail
sever
well
establish
databas
genbank
organ
genu
level
lower
may
possibl
use
rnadepend
rna
polymeras
target
viral
identif
use
mass
spectrophotometri
theori
could
provid
suffici
coverag
outbreak
investig
ibi
abbott
laboratori
use
effect
detect
type
adenovirus
influenza
virus
alphavirus
coronavirus
orthopoxvirus
potenti
power
approach
shown
recent
studi
influenza
strain
emerg
anoth
exampl
use
mass
spectrophotometri
mean
demultiplex
highli
multiplex
pcr
call
masstag
pcr
type
assay
set
primer
use
detect
broad
rang
pathogen
multiplex
pcr
instanc
primer
made
masscod
tag
qiagen
genom
consequ
primer
set
label
distinct
molecular
weight
tag
cleav
pcr
purif
unus
primer
tag
analyz
singl
quadrapol
mass
spectromet
use
positivemod
atmospher
pressur
chemic
ioniz
masstag
pcr
technolog
alreadi
proven
use
retrospect
examin
respiratori
specimen
influenzalik
ill
neg
cultur
pcr
influenza
influenza
b
masstag
pcr
assay
detect
follow
respiratori
pathogen
one
specimen
influenza
b
human
rsv
subgroup
b
human
coronavirus
sarscov
human
parainfluenza
virus
hmpv
enteroviru
human
adenoviru
mycoplasma
pneumonia
legionella
pneumophila
chlamydophila
pneumonia
streptococcu
pneumonia
haemophilu
influenza
neisseria
meningitidi
instrument
idaho
technolog
inc
salt
lake
citi
ut
usa
exampl
molecular
method
requir
batch
instead
design
take
one
sampl
molecular
result
less
hour
use
complet
autom
handsfre
method
use
system
necessari
reagent
sampl
prepar
pcr
detect
store
freezedri
pouch
contain
sever
pocket
variou
step
reagent
hydrat
sampl
ad
instrument
move
sampl
product
step
array
well
design
process
specif
target
panel
virus
bacteria
current
two
panel
evalu
stage
product
develop
includ
viral
panel
detect
adenoviru
bocaviru
coronaviru
influenza
includ
season
subtyp
influenza
b
hmpv
parainfluenza
viru
type
rsv
rhinoviru
molecular
method
distinct
advantag
convent
method
includ
abil
rapidli
develop
implement
specif
assay
newli
recogn
virus
newli
emerg
variant
coupl
capac
process
larger
number
sampl
obtain
result
less
time
convent
diagnost
approach
howev
abil
process
larg
number
sampl
impos
need
handl
sampl
larg
batch
accommod
micropl
technolog
approach
allow
use
autom
process
reduc
error
flexibl
handl
individu
sampl
requir
urgent
test
may
lost
unless
convent
test
capac
retain
either
singlespecimen
molecular
assay
randomaccess
molecular
analyz
develop
